NAKAE Susumu | Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
スポンサーリンク
概要
関連著者
-
Asano M
Inst. Med. Sci. Tokyo Univ.
-
Asano Masahide
昭和大学 薬学部
-
Sudo K
Animal Research Center Tokyo Medical University
-
Sudo Katsuko
東京大学医科学研究所 癌細胞シグナル分野
-
Sudo Katsuko
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
IWAKURA Yoichiro
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
-
NAKAE Susumu
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
-
HORAI Reiko
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
-
Nakae Susumu
Department Of Pathology Stanford University School Of Medicine
-
Horai Reiko
National Human Genome Research Institute National Institutes Of Health
-
Horai Reiko
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
Iwakura Yoichiro
東京大学医科学研究所 癌細胞シグナル分野
-
Iwai Yasuhiro
Department Of Pathology Shiga University Of Medical Science
-
Iwai Y
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
Iwakura Yoichiro
Center For Experimental Medicine And Systems Biology Institute Of Medical Science University Of Toky
-
Horai Reiko
Center For Experimental Medicine Inst. Of Medical Sci. The Univ. Of Tokyo
-
Iwakura Yoichiro
Center For Experimental Medicine And Systems Biology Inst. Of Medical Sci. The Univ. Of Tokyo
-
Sudo Katsuko
Center For Experimental Medicine Inst. Of Medical Sci. The Univ. Of Tokyo
-
Asano Masahide
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
Komiyama Yutaka
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
Sekikawa K
昭和大学 医学部第三内科学教室
-
Sekikawa Kenji
Department Of Molecular Biology And Immunology National Institute Of Agrobiological Sciences:kitasat
-
Sekikawa Kenji
Department Of Immunology National Institute Of Animal Health
-
Matsushima Koji
Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo
-
NARUMI Shosaku
Department of Molecular Preventive Medicine & SORST, Graduate School of Medicine, University of Toky
-
Narumi Shosaku
Department Of Molecular Preventive Medicine School Of Medicine University Of Tokyo
-
TAGAWA Yoh-ichi
Center for Experimental Medicine, Institute of Medical Science, The University of Tokyo
-
ASANO MASAHIDE
Institute Medicine Science, Tokyo University
-
Naruse-nakajima Chie
Institute For Experimental Animals School Of Medicine Kanazawa University Of Tokyo
-
Tagawa Yoh-ichi
Center For Experimental Medicine Institute Of Medical Science The University Of Tokyo
-
Tagawa Yoh-ichi
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
HOMMA Ikuo
Second Dept. of Physiol., Showa Univ. School of Med.
-
NAMBU Aya
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
-
YOKOYAMA Hiroshi
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo
-
UMEDA Masaomi
Research Center Kyoto, Bayer Yakuhin, Ltd
-
IWASE Michiko
Second Department of Physiology, Showa University School of Medicine
-
Homma Ikuo
Second Department Of Physiology Showa University School Of Medicine
-
Iwase Michiko
Second Department Of Physiology Showa University School Of Medicine
-
Umeda Masaomi
Research Center Kyoto Bayer Yakuhin Ltd
-
Matsushima K
Department Of Molecular Preventive Medicine & Sorst Graduate School Of Medicine University Of To
-
Nambu Aya
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
Matsumoto Kiyoshi
Department Of Molecular Preventive Medicine School Of Medicine University Of Tokyo
-
Matsushima Koji
Department Of Molecular Preventive Medicine School Of Medicine University Of Tokyo
-
Matsushima Koji
Department Of Hygiene Faculty Of Medicine University Of Tokyo
-
Yokoyama Hiroshi
Center For Experimental Medicine Institute Of Medical Science University Of Tokyo
-
NARUMI Shosaku
Department of Internal Medicine, Keio University School of Medicine
著作論文
- IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity
- IL-1 is required for allergen-specific T_h2 cell activation and the development of airway hypersensitivity response
- IL-1-induced tumor necrosis factor-α elicits inflammatory cell infiltration in the skin by inducing IFN-γ-inducible protein 10 in the elicitation phase of the contact hypersensitivity response